Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS) Income Statement Analysis

See more : Kleos Space S.A. (KSS.AX) Income Statement Analysis – Financial Results

Complete financial analysis of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.

You may be interested

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)

Industry: Packaged Foods

Sector: Consumer Defensive

Website: https://www.sdblcy.com

About Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. produces and sells functional sugar in China and internationally. It offers oligosaccharide products, such as oligofructose powder and liquid, isomalto oligosaccharide powder and liquid, xylo oligosaccharides, and galto oligosaccharides; dietary fiber products, including polydextrose and resistant dextrin; sugar alcohol products comprising crystalline maltitol and maltitol syrup; starch sugar products that include high fructose syrup, maltodextrin, and high maltose powder; special sugar products that consists of mono cake, bakery, and bread syrups; and fermentation products. The company was founded in 2005 and is based in Yucheng, China.

Metric	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	868.26M	721.89M	653.36M	499.62M	421.05M	355.53M	310.61M	335.52M
Cost of Revenue	584.10M	493.34M	471.68M	335.91M	261.62M	234.73M	191.72M	209.22M
Gross Profit	284.16M	228.56M	181.68M	163.72M	159.43M	120.80M	118.89M	126.30M
Gross Profit Ratio	32.73%	31.66%	27.81%	32.77%	37.86%	33.98%	38.28%	37.64%
Research & Development	32.56M	27.03M	23.26M	15.37M	15.02M	11.08M	10.36M	10.61M
General & Administrative	11.29M	10.37M	12.11M	9.01M	6.80M	3.57M	9.41M	11.77M
Selling & Marketing	8.69M	24.45M	20.31M	16.76M	30.20M	22.18M	16.53M	15.61M
SG&A	19.98M	34.82M	32.42M	25.77M	37.00M	25.75M	25.95M	27.38M
Other Expenses	7.93M	8.27M	6.08M	3.85M	6.46M	-1.94M	-1.70M	2.89M
Operating Expenses	60.47M	70.13M	61.76M	44.99M	58.48M	42.12M	37.68M	42.01M
Cost & Expenses	644.57M	563.47M	533.44M	380.90M	320.10M	276.85M	229.40M	251.24M
Interest Income	3.97M	3.87M	1.70M	562.33K	372.26K	740.09K	0.00	3.31M
Interest Expense	2.43M	65.98K	1.04M	4.21M	2.37M	4.50M	3.83M	19.09M
Depreciation & Amortization	47.47M	48.72M	47.77M	43.27M	32.58M	27.89M	25.94M	24.74M
EBITDA	271.42M	222.01M	167.73M	157.73M	131.18M	108.16M	105.74M	111.54M
EBITDA Ratio	31.26%	31.23%	25.68%	32.02%	31.86%	30.87%	34.69%	35.21%
Operating Income	223.69M	176.48M	120.25M	110.75M	98.73M	77.64M	75.84M	73.59M
Operating Income Ratio	25.76%	24.45%	18.40%	22.17%	23.45%	21.84%	24.42%	21.93%
Total Other Income/Expenses	-2.17M	-3.39M	-1.47M	-662.74K	-2.63M	-1.94M	-1.70M	2.89M
Income Before Tax	221.52M	173.09M	118.77M	110.09M	96.10M	75.70M	74.14M	76.48M
Income Before Tax Ratio	25.51%	23.98%	18.18%	22.03%	22.82%	21.29%	23.87%	22.79%
Income Tax Expense	28.52M	22.29M	14.29M	14.54M	13.31M	10.40M	10.41M	11.68M
Net Income	193.00M	150.75M	104.48M	95.55M	82.78M	65.30M	63.73M	64.80M
Net Income Ratio	22.23%	20.88%	15.99%	19.12%	19.66%	18.37%	20.52%	19.31%
EPS	0.78	0.61	0.42	0.38	0.33	0.69	0.34	0.41
EPS Diluted	0.78	0.61	0.42	0.38	0.33	0.69	0.34	0.41
Weighted Avg Shares Out	247.43M	248.38M	248.53M	248.53M	248.53M	94.64M	186.45M	158.74M
Weighted Avg Shares Out (Dil)	247.43M	248.38M	248.53M	248.53M	248.53M	94.64M	186.45M	158.76M

No news found for: 605016.SS

Source: https://incomestatements.info
Category: Stock Reports

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories